Four more years! Prediabetes patients should try to delay the onset of diabetes by at least four years to significantly lower their risk of early death and complications such as heart attack or stroke, a new study finds. With prediabetes, a person’s blood sugar is above average — but not high enough for a Type…
Specialty Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI’m not a medical professional.Infectious DiseaseIntegrative/Complementary MedicineInternal MedicineInternal Medicine-PediatricsMedical Education and SimulationMedical PhysicsMedical StudentNephrologyNeurological SurgeryNeurologyNuclear MedicineNutritionObstetrics and GynecologyOccupational HealthOncologyOphthalmologyOptometryOral MedicineOrthopaedicsOsteopathic MedicineOtolaryngologyPain ManagementPalliative CarePathologyPediatricsPediatric SurgeryPharmacologyPhysical Medicine and RehabilitationPlastic SurgeryPodiatryPreventive MedicinePsychiatryPsychologyPulmonologyRadiation OncologyRadiologyRheumatologySubstance Use and AddictionSurgeryTherapeuticsTraumaUrologyMiscellaneous Source…
A comprehensive study involving 16,827 patients has brought to light potential risks associated with Ozempic, a medication widely used for managing type 2 diabetes and obesity. Ozempic, known generically as semaglutide, was approved in 2017 by the U.S. Food and Drug Administration (FDA) for use in adults with type 2 diabetes. Ozempic is a weekly…
Demographic characteristics In this study, a total of 300 male and female subjects were initially enrolled, with 293 completing the study. Among the participants, 46 males and 101 females were in the Feroglobin treatment, and 33 males and 113 females were in the standard of care. The average age among Feroglobin treatment was 36.10 ± 11.79 years, while…